International Journal of Molecular Sciences (Apr 2021)

Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions

  • Maria Notarnicola,
  • Alberto Ruben Osella,
  • Maria Gabriella Caruso,
  • Pasqua Letizia Pesole,
  • Antonio Lippolis,
  • Valeria Tutino,
  • Caterina Bonfiglio,
  • Valentina De Nunzio,
  • Maria Principia Scavo,
  • Antonella Mirizzi,
  • Isabella Franco,
  • Tamara Lippolis,
  • Rosalba D’Alessandro,
  • Maria Grazia Refolo,
  • Caterina Messa

DOI
https://doi.org/10.3390/ijms22083899
Journal volume & issue
Vol. 22, no. 8
p. 3899

Abstract

Read online

Nonalcoholic fatty liver disease (NAFLD) is considered a hepatic manifestation of metabolic syndrome, characterized from pathological changes in lipid and carbohydrate metabolism. Its main characteristics are excessive lipid accumulation and oxidative stress, which create a lipotoxic environment in hepatocytes leading to liver injury. Recently, many studies have focused on the identification of the genetic and epigenetic modifications that also contribute to NAFLD pathogenesis and their prognostic implications. The present review is aimed to discuss on cellular and metabolic alterations associated with NAFLD, which can be helpful to identify new noninvasive biomarkers. The identification of accumulated lipids in the cell membranes, as well as circulating cytokeratins and exosomes, provides new insights in understanding of NAFLD. This review also suggests that lifestyle modifications remain the main prevention and/or treatment for NAFLD.

Keywords